Who Can Prescribe Semaglutide for Weight Loss?

Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide for weight loss requires a prescription from a licensed healthcare provider, but the specific qualifications vary by state and prescriber type. In the United States, approximately 1 in 8 adults now use GLP-1 medications, making access and prescriber expertise increasingly important for safe, effective treatment.

Medical Doctors and Licensed Physicians

Medical doctors (MDs) hold the broadest authority to prescribe semaglutide across all states and specialties. Any licensed physician—whether in family medicine, internal medicine, bariatrics, endocrinology, or primary care—can legally write a semaglutide prescription for weight loss if it aligns with their scope of practice and state law. Most MDs have access to continuing education on GLP-1 mechanisms and patient selection, though expertise levels vary based on individual training and experience.

Doctors of Osteopathic Medicine (DOs) possess equivalent prescribing authority to MDs and can prescribe semaglutide for weight loss in all states. DOs receive additional training in musculoskeletal medicine but follow the same regulatory pathways for medication authorization. Both MDs and DOs must maintain current licensure and comply with state medical board regulations.

Nurse Practitioners and Physician Assistants

Nurse practitioners (NPs) and physician assistants (PAs) can prescribe semaglutide in most states, though regulations differ significantly by location. NPs typically require a master's degree, clinical certification, and current licensure; PAs must complete accredited graduate programs and pass national certification exams. Both professions increasingly specialize in weight management, metabolic health, and GLP-1 therapy, often bringing detailed patient education and follow-up care.

Some states impose collaborative or supervisory requirements on NPs and PAs, meaning they may need physician oversight or joint-authorization protocols for certain medications. PlexusDx works with licensed NPs and PAs nationwide who meet their individual state's prescribing standards, ensuring every patient receives care from qualified, authorized providers.

Specialized Prescribers in Weight Loss Medicine

Board-certified obesity medicine specialists represent a growing category of prescribers with advanced credentials in GLP-1 therapy and metabolic conditions. These physicians complete additional fellowship training, pass specialty board exams, and maintain expertise in semaglutide dosing, patient selection, and complication management. Bariatric surgeons and endocrinologists also frequently prescribe semaglutide, drawing on deep knowledge of metabolic pathways and patient monitoring.

Telemedicine providers and concierge practitioners licensed through PlexusDx undergo credential verification to confirm valid medical licensure and prescribing authority in the patient's state. This model expands access to semaglutide prescriptions while maintaining clinical standards and legal compliance across all 50 states.

State Regulations and PlexusDx Access Standards

Semaglutide prescription requirements and prescriber qualifications vary by state law, with some states imposing stricter credentialing or documentation standards than others. PlexusDx verifies that all partnered prescribers hold current, unrestricted licensure and comply with their state's specific regulations for weight-loss medication authorization. No national database unifies prescriber credentials, so PlexusDx conducts individual state-level verification to ensure legal and safe treatment delivery.

PlexusDx serves all 50 states without insurance requirements, meaning patients access prescribers regardless of employer health plans or insurance status. Once matched with a licensed prescriber through PlexusDx, patients receive compounded semaglutide from licensed 503A compounding pharmacies, with HSA/FSA payment options available and pricing at $189/mo month-to-month, or from $149/mo on the 6-month plan regardless of dose level.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can my primary care doctor prescribe semaglutide for weight loss?

Yes. Any licensed MD, DO, NP, or PA holding current prescribing authority in your state can prescribe semaglutide for weight loss. PlexusDx connects you with qualified prescribers in your state who can initiate semaglutide therapy during your first consultation, with ongoing support and monitoring included in your care plan.

Do I need to see a weight loss specialist to get semaglutide?

No. While board-certified obesity medicine specialists bring advanced expertise, any licensed prescriber can legally order semaglutide for weight loss if it is clinically appropriate for your health profile. PlexusDx partners with generalist physicians and specialized weight-loss providers, giving you choice in prescriber expertise and approach.

What if my state has restrictions on prescriber types?

PlexusDx verifies state-specific prescribing regulations before matching you with a provider. Some states limit prescribing authority for certain professions or require collaborative agreements; PlexusDx ensures your prescriber meets all local legal requirements. We serve all 50 states, and our credential-verification process confirms prescriber licensure matches your state's standards.

How do I know if a PlexusDx prescriber is legitimate?

Every PlexusDx prescriber undergoes credential verification confirming current state medical licensure, prescribing authority, and legal standing. Semaglutide is dispensed from licensed 503A compounding pharmacies, and your treatment plan includes ongoing clinical oversight. You can verify prescriber licensure independently through your state medical board's website.

Can genetic testing help my prescriber choose the right semaglutide approach?

Yes. The PlexusDx Precision Peptide Genetic Test ($298) analyzes genetic variants like GIPR rs1800437 to reveal your peptide-pathway predispositions across 14 metabolic pathways. This data helps your prescriber personalize your semaglutide dosing and response expectations, refining therapy beyond standard protocols.

Related Reading

• Semaglutide For Weight Loss 2
• Semaglutide Tablets For Weight Loss
• Semaglutide Pills For Weight Loss
• Oral Semaglutide Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.